Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 50 Records) |
Query Trace: RECK[original query] |
---|
EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study. Lung cancer (Amsterdam, Netherlands) 2017 11 113 37-44. Han Baohui, Tjulandin Sergei, Hagiwara Koichi, Normanno Nicola, Wulandari Laksmi, Laktionov Konstantin, Hudoyo Achmad, He Yong, Zhang Yi-Ping, Wang Meng-Zhao, Liu Chien Ying, Ratcliffe Marianne, McCormack Rose, Reck Mart |
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC. The New England journal of medicine 2018 6 378 (24): 2288-2301. Socinski Mark A, Jotte Robert M, Cappuzzo Federico, Orlandi Francisco, Stroyakovskiy Daniil, Nogami Naoyuki, Rodríguez-Abreu Delvys, Moro-Sibilot Denis, Thomas Christian A, Barlesi Fabrice, Finley Gene, Kelsch Claudia, Lee Anthony, Coleman Shelley, Deng Yu, Shen Yijing, Kowanetz Marcin, Lopez-Chavez Ariel, Sandler Alan, Reck Martin, |
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer. Annals of oncology : official journal of the European Society for Medical Oncology 2018 6 29 (8): 1701-1709. Bonomi P D, Gandara D, Hirsch F R, Kerr K M, Obasaju C, Paz-Ares L, Bellomo C, Bradley J D, Bunn P A, Culligan M, Jett J R, Kim E S, Langer C J, Natale R B, Novello S, Pérol M, Ramalingam S S, Reck M, Reynolds C H, Smit E F, Socinski M A, Spigel D R, Vansteenkiste J F, Wakelee H, Thatcher |
Preselection of EGFR mutations in non-small-cell lung cancer patients by immunohistochemistry: comparison with DNA-sequencing, EGFR wild-type expression, gene copy number gain and clinicopathological data. Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 2018 3 58 (4): 1175-1184. Gaber Rania, Watermann Iris, Kugler Christian, Vollmer Ekkehard, Perner Sven, Reck Martin, Goldmann Torst |
Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer (RELAY): Phase Ib Results. Clinical lung cancer 2018 1 19 (3): 213-220.e4. Reck Martin, Garon Edward B, Paz-Ares Luis, Ponce Santiago, Jaime Jesus Corral, Juan Oscar, Nadal Ernest, Kiura Katsuyuki, Widau Ryan C, He Shuang, Dalal Rita, Lee Pablo, Nakagawa Kazuhi |
Circulating free tumor-derived DNA to detect EGFR mutations in patients with advanced NSCLC: French subset analysis of the ASSESS study. Journal of thoracic disease 2019 6 11 (4): 1370-1378. Denis Marc G, Lafourcade Marie-Pierre, Le Garff Gwenaëlle, Dayen Charles, Falchero Lionel, Thomas Pascal, Locher Chrystèle, Oliviero Gérard, Licour Muriel, Reck Martin, Normanno Nicola, Molinier Olivi |
Frequency of Contact Allergy to Implanted Cardiac Devices. JAMA dermatology 2019 4 155 (6): 749-752. Gold Matthew, Nath Neel, Green Cynthia, Atwater Amber Re |
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial. The Lancet. Respiratory medicine 2019 3 7 (5): 387-401. Reck Martin, Mok Tony S K, Nishio Makoto, Jotte Robert M, Cappuzzo Federico, Orlandi Francisco, Stroyakovskiy Daniil, Nogami Naoyuki, Rodríguez-Abreu Delvys, Moro-Sibilot Denis, Thomas Christian A, Barlesi Fabrice, Finley Gene, Lee Anthony, Coleman Shelley, Deng Yu, Kowanetz Marcin, Shankar Geetha, Lin Wei, Socinski Mark A, |
Variants of WNT7A and GPR124 are associated with hemorrhagic transformation following intravenous thrombolysis in ischemic stroke. CNS neuroscience & therapeutics 2020 9 27 (1): 71-81. Ta Song, Rong Xianfang, Guo Zhen-Ni, Jin Hang, Zhang Peng, Li Fenge, Li Zhihuan, Lin Lilong, Zheng Chenqing, Gu Qingquan, Zhang Yuan, Liu Wenlan, Yang Yi, Chang Junl |
Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA. EBioMedicine 2020 Nov 62 103103. Dietz Steffen, Christopoulos Petros, Yuan Zhao, Angeles Arlou Kristina, Gu Lisa, Volckmar Anna-Lena, Ogrodnik Simon J, Janke Florian, Fratte Chiara Dalle, Zemojtel Tomasz, Schneider Marc A, Kazdal Daniel, Endris Volker, Meister Michael, Muley Thomas, Cecchin Erika, Reck Martin, Schlesner Matthias, Thomas Michael, Stenzinger Albrecht, Sültmann Holg |
Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated Metastatic EGFR-Mutated NSCLC: RELAY Japanese Subset. JTO clinical and research reports 2021 9 2 (6): 100171. Nishio Kazuto, Seto Takashi, Nishio Makoto, Reck Martin, Garon Edward B, Sakai Kazuko, Goto Koichi, Kato Terufumi, Nakanishi Yoichi, Takahashi Toshiaki, Yamamoto Nobuyuki, Kiura Katsuyuki, Ohe Yuichiro, Tamura Tomohide, Visseren-Grul Carla, Frimodt-Moller Bente, Hozak Rebecca R, Wijayawardana Sameera R, Zimmermann Annamaria, Homma Gosuke, Enatsu Sotaro, Nakagawa Kazuhi |
Contact Allergy in Canada Versus United States: Analysis of the North American Contact Dermatitis Group Data 2005-2016. Dermatitis : contact, atopic, occupational, drug 2021 7 32 (6): 421-429. Atwater Amber Reck, Ward Jordan Maxwell, Liu Beiyu, Warshaw Erin M, DeKoven Joel G, Silverberg Jonathan I, Taylor James S, Belsito Donald V, Fowler Joseph F, Maibach Howard I, Reeder Margo J, Pratt Melanie D, Zug Kathryn A, Sasseville Denis, DeLeo Vincent |
RELAY Subgroup Analyses by EGFR Ex19del and Ex21L858R Mutations for Ramucirumab Plus Erlotinib in Metastatic Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 7 27 (19): 5258-5271. Nakagawa Kazuhiko, Nadal Ernest, Garon Edward B, Nishio Makoto, Seto Takashi, Yamamoto Nobuyuki, Park Keunchil, Shih Jin-Yuan, Paz-Ares Luis, Frimodt-Moller Bente, Zimmermann Annamaria H, Wijayawardana Sameera, Visseren-Grul Carla, Reck Mart |
Two RECK Splice Variants (Long and Short) Are Differentially Expressed in Patients with Stable and Unstable Coronary Artery Disease: A Pilot Study. Genes 2021 7 12 (6): . Vancheri Chiara, Morini Elena, Prandi Francesca Romana, Alkhoury Elie, Celotto Roberto, Romeo Francesco, Novelli Giuseppe, Amati Frances |
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 3 39 (12): 1349-1359. Owonikoko Taofeek K, Park Keunchil, Govindan Ramaswamy, Ready Neal, Reck Martin, Peters Solange, Dakhil Shaker R, Navarro Alejandro, Rodríguez-Cid Jerónimo, Schenker Michael, Lee Jong-Seok, Gutierrez Vanesa, Percent Ivor, Morgensztern Daniel, Barrios Carlos H, Greillier Laurent, Baka Sofia, Patel Miten, Lin Wen Hong, Selvaggi Giovanni, Baudelet Christine, Baden Jonathan, Pandya Dimple, Doshi Parul, Kim Hye Ry |
Contact dermatitis associated with preservatives: Retrospective analysis of North American Contact Dermatitis Group data, 1994 through 2016. Journal of the American Academy of Dermatology 2021 2 84 (4): 965-976. Atwater Amber Reck, Petty Amy J, Liu Beiyu, Green Cynthia L, Silverberg Jonathan I, DeKoven Joel G, Belsito Donald V, Reeder Margo J, Sasseville Denis, Taylor James S, Maibach Howard I, Zirwas Matthew J, Marks James G, Zug Kathryn A, Fowler Joseph F, Pratt Melanie D, DeLeo Vincent A, Warshaw Erin |
RELAY, Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients with Untreated, Epidermal Growth Factor Receptor Mutation-Positive, Metastatic Non-Small-Cell Lung Cancer: Safety Profile and Manageability. Drug safety 2021 12 45 (1): 45-64. Nadal Ernest, Horinouchi Hidehito, Shih Jin-Yuan, Nakagawa Kazuhiko, Reck Martin, Garon Edward B, Wei Yu-Feng, Kollmeier Jens, Frimodt-Moller Bente, Barrett Emily, Lipkovich Olga, Visseren-Grul Carla, Novello Silv |
IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Oct . Nogami Naoyuki, Barlesi Fabrice, Socinski Mark A, Reck Martin, Thomas Christian A, Cappuzzo Federico, Mok Tony S K, Finley Gene, Aerts Joachim G, Orlandi Francisco, Moro-Sibilot Denis, Jotte Robert M, Stroyakovskiy Daniil, Villaruz Liza C, Rodríguez-Abreu Delvys, Wan-Teck Lim Darren, Merritt David, Coleman Shelley, Lee Anthony, Shankar Geetha, Yu Wei, Bara Ilze, Nishio Mako |
Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ? 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 Jan JCO2003579. Boyer Michael, ?endur Mehmet A N, Rodríguez-Abreu Delvys, Park Keunchil, Lee Dae Ho, Çiçin Irfan, Yumuk Perran Fulden, Orlandi Francisco J, Leal Ticiana A, Molinier Olivier, Soparattanapaisarn Nopadol, Langleben Adrian, Califano Raffaele, Medgyasszay Balazs, Hsia Te-Chun, Otterson Gregory A, Xu Lu, Piperdi Bilal, Samkari Ayman, Reck Martin, |
RECK gene polymorphisms in hepatitis B-related hepatocellular carcinoma: A case-control study. Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 2022 Aug 23 (3): 201-205. Said Ebada M, Salem Abdelhamed A, Shousha Hend I, Ahmad Enas S, Alazzouny Mahmoud A, Ahmed Inas A, Elfeky Hala M, Abdelsalam Fatma |
RECK Variants are Associated with Clinicopathological Features and Decreased Susceptibility in Mexican Patients with Colorectal Cancer. The Tohoku journal of experimental medicine 2022 4 257 (2): 163-169. María Márquez-González Rosa, Margarita Saucedo-Sariñana Anilú, Barros-Núñez Patricio, Patricia Gallegos-Arreola Martha, Ibet Juárez-Vázquez Clara, Daniel Pineda-Razo Tomás, Eugenia Marin-Contreras María, Esperanza Flores-Martínez Silvia, Alejandra Rosales-Reynoso Móni |
Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial. Journal for immunotherapy of cancer 2022 02 10 (2): . West Howard Jack, McCleland Mark, Cappuzzo Federico, Reck Martin, Mok Tony Sk, Jotte Robert M, Nishio Makoto, Kim Eugene, Morris Stefanie, Zou Wei, Shames David, Das Thakur Meghna, Shankar Geetha, Socinski Mark |
Older patients with EGFR mutation-positive non-small cell lung cancer treated with afatinib in clinical practice: A subset analysis of the non-interventional GIDEON study. Journal of geriatric oncology 2022 11 . Brueckl Wolfgang M, Reck Martin, Schäfer Harald, Neben Kai, Griesinger Frank, Rawluk Justyna, Krüger Stefan, Kokowski Konrad, Ficker Joachim H, Möller Miriam, Schueler Andrea, Laack Ecka |
NSCLC with uncommon EGFR mutations treated with atezolizumab plus bevacizumab and chemotherapy. Lung cancer (Amsterdam, Netherlands) 2022 11 174 141-145. Trummer Arne, Bethge Andre, Dickgreber Nicolas, Dittrich Ina, Golpon Heiko, Hoffknecht Petra, Overbeck Tobias R, Wesseler Claas, Reck Mart |
UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2022 10 18 (2): 169-180. Bar Jair, Peled Nir, Schokrpur Shiruyeh, Wolner Mirjana, Rotem Ofer, Girard Nicolas, Aboubakar Nana Frank, Derijcke Sofie, Kian Waleed, Patel Sandip, Gantz-Sorotsky Hadas, Zer Alona, Moskovitz Mor, Metro Giulio, Rottenberg Yakir, Calles Antonio, Hochmair Maximilian, Cuppens Kristof, Decoster Lynn, Reck Martin, Limon Dror, Rodriguez Estelamari, Astaras Christoforos, Bettini Adrienne, Häfliger Simon, Addeo Alfre |
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small cell lung cancer: exposure-response relationship. Cancer chemotherapy and pharmacology 2022 Jul . Nakagawa Kazuhiko, Garon Edward B, Gao Ling, Callies Sophie, Zimmermann Annamaria, Walgren Richard, Visseren-Grul Carla, Reck Mart |
Ramucirumab plus erlotinib versus placebo plus erlotinib in previously untreated EGFR-mutated metastatic non-small-cell lung cancer (RELAY): exploratory analysis of next-generation sequencing results. ESMO open 2023 6 8 (4): 101580. E B Garon, M Reck, K Nishio, J V Heymach, M Nishio, S Novello, L Paz-Ares, S Popat, S Ponce Aix, H Graham, B D Butts, C Visseren-Grul, K Nakagawa, |
RELAY, Ramucirumab Plus Erlotinib (RAM+ERL) in Untreated Metastatic EGFR-Mutant NSCLC (EGFR+ NSCLC): Association Between TP53 Status and Clinical Outcome. Clinical lung cancer 2023 4 . Makoto Nishio, Luis Paz-Ares, Martin Reck, Kazuhiko Nakagawa, Edward B Garon, Sanjay Popat, Matteo Ceccarelli, Hillary T Graham, Carla Visseren-Grul, Silvia Novel |
Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC. JTO clinical and research reports 2023 2 4 (1): 100431. Garassino Marina C, Gadgeel Shirish, Novello Silvia, Halmos Balazs, Felip Enriqueta, Speranza Giovanna, Hui Rina, Garon Edward B, Horinouchi Hidehito, Sugawara Shunichi, Rodriguez-Abreu Delvys, Reck Martin, Cristescu Razvan, Aurora-Garg Deepti, Loboda Andrey, Lunceford Jared, Kobie Julie, Ayers Mark, Piperdi Bilal, Pietanza M Catherine, Paz-Ares Lu |
First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations. European journal of cancer (Oxford, England : 1990) 2024 1 199 113556. Miriam Blasi, Jonas Kuon, Heike Lüders, Daniel Misch, Diego Kauffmann-Guerrero, Moritz Hilbrandt, Daniel Kazdal, Roger-Fei Falkenstern-Ge, Björn Hackanson, Sebastian Dintner, Martin Faehling, Martina Kirchner, Anna-Lena Volckmar, Hans-Georg Kopp, Michael Allgäuer, Christian Grohé, Amanda Tufman, Martin Reck, Nikolaj Frost, Albrecht Stenzinger, Michael Thomas, Petros Christopoul |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: